Jones Financial Companies’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.46K Sell
3,021
-5,810
-66% -$14.8K ﹤0.01% 3861
2026
Q1
$17.1K Buy
8,831
+360
+4% +$845 ﹤0.01% 3352
2025
Q4
$23K Buy
8,471
+3,000
+55% +$9.85K ﹤0.01% 2873
2025
Q3
$22.1K Buy
5,471
+2,416
+79% +$10.6K ﹤0.01% 2744
2025
Q2
$15K Buy
3,055
+468
+18% +$2.03K ﹤0.01% 2717
2025
Q1
$11.6K Hold
2,587
– – ﹤0.01% 2644
2024
Q4
$12K Buy
2,587
+100
+4% +$550 ﹤0.01% 2451
2024
Q3
$17K Buy
+2,487
New +$19.5K ﹤0.01% 2014

Other funds holding GDRX

Jones Financial Companies's GDRX Position: Q2 2026 in Review

Jones Financial Companies reduced its GoodRx Holdings (GDRX) stake by 66% in Q2 2026, selling an estimated $14.8K and leaving 3,021 shares worth $8.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3861.

Jones Financial Companies first reported a position in GDRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $23K in Q4 2025. 163 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Jones Financial Companies held 3,021 shares of GoodRx Holdings worth $8.46K as of Q2 2026.
  • Jones Financial Companies sold 5,810 GoodRx Holdings shares in Q2 2026, an estimated $14.8K.
  • GoodRx Holdings made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3861 holding.
  • Jones Financial Companies first reported a position in GoodRx Holdings in Q3 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's GoodRx Holdings position peaked at $23K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.